Table 1. Objectives of the Clinical Trial Design Task Force.

IDSC – Investigational Drug Steering Committee; NCI – National Cancer Institute.

Provide guidance to the IDSC on current best practice for all aspects of early clinical trial design

Identify areas where further research and investigation are needed to improve the quality and or efficiency of early clinical trial design

Assist NCI and the IDSC or as needed with the implementation of recommendations for further research and investigation

Collaborate with other IDSC taskforces to minimize duplication of efforts

Develop and implement a plan to disseminate and publish the recommendations and guidance formulated by the taskforce and approved by the IDSC